New Trial to Test MRD-Guided Escalation in Advanced Melanoma
A newly announced trial will evaluate whether measurable residual disease testing can trigger earlier treatment escalation in advanced melanoma, potentially reshaping surveillance.
Topic
Measurable Residual Disease
Topic